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The purpose of the present work was to develop optimized novel enteric microcapsules containing diclofenac sodium, a 
non steroidal anti inflammatory drug (NSAID) used for rheumatoid arthritis, for improved delivery and to diminish its 
adverse effect after oral administration. The microcapsule was prepared by using different polymers and the enteric coating 
was provided by using an innovative technique combining wet granulation method and thermal change method. This work 
also investigated different levels of enteric polymers like cellulose acetate phthalate (CAP) (X1) and ethyl cellulose (EC) 
(X2) and the stirring speed during coating ethyl cellulose (X3), by using 2
3 full factorial design. The dependent variables 
assessed were % yield (Y1), Q8 (% drug released after 8 hour) (Y2), n (Diffusion coefficient) (Y3), DEE (Drug entrapment 
efficiency) (Y4). The main effect and interaction terms were quantitatively evaluated using a mathematical model. The 
prepared microcapsules were evaluated for percentage drug dissolved, scanning electron microscopy, drug excipient 
interaction, angle of repose, particle size. Mean dissolution time (MDT) was used to compare dissolution patterns obtained. 
The results showed that X1 and X2 significantly affected the release properties.  
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INTRODUCTION 
Diclofenac sodium, a potent non steroidal anti 
inflammatory drug with pronounced analgesic properties, 
is used in the long term treatment of rheumatoid arthritis, 
osteoarthritis and ankylosing spondylitis. Its biological half 
life has been reported as 1–2 hour. However 
gastrointestinal side effects such as bleeding, ulceration or 
perforation of intestinal wall are commonly seen with 
diclofenac sodium administration (1). Due to short 
biological half life and associated adverse effects, it is 
considered as an ideal candidate for controlled drug 
delivery. Under ideal conditions, a sustained-release 
formulation maintains therapeutic blood level of a drug for 
a specific period of time. Oral controlled-release dosage 
forms have been developed and studied to restrict the 
delivery systems to specific regions of the gastrointestinal 
tract as well as to improve the pharmacological activity 
and to reduce toxic effects (2). Development of new drug 
molecule is expensive and time consuming. Improving 
safety, efficacy ratio of ‘old’ drugs has been attempted 
using different methods such as individualizing drug 
therapy, dose titration and therapeutic drug monitoring. 
Delivering drug at controlled rate, slow delivery, and in 
targeted fashion are other very attractive methods and have 
been pursued very vigorously. In the present work, an 
innovative method was employed to prepare dual coated 
enteric microcapsules of diclofenac sodium. Enteric-coated 
products are designed to remain intact in the stomach and 
then to release the active substance in the upper intestine 
(3). The enteric microcapsules were prepared by 
combining wet granulation and thermal change methods. 
Two polymers offered resistance for gastric erosion; 
enteric cellulose based polymer (CAP) and a water 
insoluble hydrophobic polymer, EC (4, 5). The drug was 
wet granulated using aqueous acacia mucilage with CAP 
and then coated with EC by thermal change method. The 
objective of the study was to develop optimized enteric 
microcapsules containing diclofenac sodium as model 
drug. Optimization with factorial designs and analysis of 
the response is a powerful, efficient and systematic tool 
that shortens the time required for the development of 
pharmaceutical dosage forms and improves research and 
development work (6). Independent formulation variables 
such as amount of CAP, amount of EC and stirring speed 
during coating were examined. The dependent variables 
assessed were % Yield (Y1), Q8 (% drug released at 8 
hour) (Y2), n (Diffusion coefficient) (Y3), DEE (Drug 
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entrapment efficiency) (Y4). Regression analysis was 
performed to validate the model by comparing the 
experimental results with the theoretical values of the 
responses.  
 
MATERIALS AND METHODS 
Diclofenac sodium was generously provided as gift sample 
by Emcure Pharmaceuticals Ltd., Pune. Cellulose acetate 
phthalate (CAP) & ethyl cellulose (EC), cyclohexane, were 
procured from Loba Chemicals, Mumbai. Other 
ingredients used were of analytical grade and procured 
from commercial source.  
 
Experimental design 
Factorial design is an experimental technique by which 
factors involved in a process can be identified and their 
relative importance assessed. It is thus a means of 
separating those factors that are important from those that 
are not and identifying the interactions, if any, between the 
factors chosen. Thus the construction of a factorial design 
involves the selection of parameters and the choice of 
responses. 
Full factorial design is one of the best tools to study the 
effect of different variables on the quality determinant 
parameters of any formulation. Eight formulations were 
prepared according to a 23 factorial design employing the 
qualitative factors and levels shown in Tables 1 and 2.  
 
Preparation of microcapsules: 
Diclofenac microcapsules were prepared by using a simple 
but novel process that was designed by combining wet 
granulation with thermal change method. Diclofenac was 
mixed with CAP; the resulting mixture was granulated 
with 30% w/w aqueous acacia mucilage and dried at 50ºC. 
Dried granules of uniform size (No. 30/40) were further 
encapsulated with ethyl cellulose by thermal change 
method. The EC coating was done on drug – CAP core by 
using cyclohexane as solvent for EC and changing the 
temperature from 80ºC to room temperature with 
continuous stirring. 
 
Evaluation of microcapsules: 
Drug Content: 
Drug content in each batch was determined by weighing 
100mg of microcapsules and crushing them in a clean 
mortar. 50mg of the crushed microcapsules were 
transferred into (50ml) volumetric flask with 10ml 
methanol and 20ml of phosphate buffer pH 7.4 and then 
sonicated for 15 minutes. An aliquot was withdrawn, 
filtered through millipore filter and suitably diluted and 
assayed spectrophotometrically (UV – 1700, SHIMADZU 
CORPORATION, Japan) at 276nm, using the same 
medium as a blank. The percentage drug entrapment and 
yield were calculated as follows (7): 
% Drug entrapment = [Practical drug content / Theoretical 
drug content] x 100 
Scanning electron microscopy: 
Surface morphology of the prepared microcapsule was 
studied by using Scanning Electron Microscope (SEM) 
(Jeol JSM – 6700F, Japan). The sample for SEM was 
prepared by lightly sprinkling the microcapsules on a 
double adhesive tape stuck to an aluminum stub. The stubs 
were then coated with gold and photomicrographs were 
taken.  
Micromeritic properties: 
Particle size distribution analysis was done by sieve 
method(8). Flowability of microcapsule was tested by 
angle of repose, it was determined according to the method 
reported by Abdelkader et. al (9). 
Drug Excipient Interaction: 
To determine any interaction between drug and polymer, 
Fourier Transform Infrared (FTIR) study was carried out. 
FTIR spectra were recorded on FTIR–8400S 
(SHIMADZU CORPORATION, Japan). Samples were 
compressed with Potassium bromide and transformed into 
disk. Disk was applied to the centre of the sample holding 
device and scanned between 4000–400cm–1 at a resolution 
of 4cm–1. The IR scans were processed using IR Solution 
and represented as percentage Transmittance on a common 
scale. 
In vitro release study:  
The drug release studies were carried out using the USP 
XXIII dissolution apparatus I (basket method; VDA – 8DR 
USP Standard, VEEGO, Kolkata, India). In the first step, 
the microcapsules were evaluated by dissolution testing in 
900ml 0.1N HCl solution at 37ºC at a basket speed of 50 
rpm. Accurately weighed sample containing the equivalent 
of about 100mg of diclofenac sodium were introduced in 
the dissolution medium. After 1 and 2 h, the samples were 
taken from the vessel, passed through a filter, assayed by 
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spectrophotometer (UV – 1700, SHIMADZU 
CORPORATION, Japan) at 276 nm. Sink conditions 
prevailed during the drug release studies. The initial 
volume of the dissolution fluid was maintained by adding 
fresh dissolution fluid after each withdrawal.  In the 
second step, acidic medium was immediately replaced 
with the phosphate buffer (pH 7.4), then the dissolution 
testing was continued. Additional samples were taken in 
the same way as before at different time intervals and 
analyzed spectrophotometrically at 276 nm. 
 
Mean Dissolution Time: 
Mean dissolution time (MDT) is considered as a basis for 
comparison of the dissolution rates and was estimated by 
the following equation (9):  
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where i is dissolution sample number, n is number of 
dissolution sample times, tmid is time at the midpoint 
between times ti and ti-1, and ΔM is the amount of 
diclofenac sodium dissolved (μg) between times ti and ti-1. 
Data Analysis 
The results obtained were statistically validated using MS 
Excel (Microsoft) & Sigmaplot. The models were 
evaluated in terms of statistically significant coefficients 
and R2 values. Contour plots were provided by the 
Sigmaplot software. 
 
Table 1: Level of Investigated variables 
 
Codes 
Independent Variables 
Amount of CAP (X1) 
(mg) 
Amount of EC (X2) 
(mg) 
Stirring speed during coating 
(X3) (rpm) 
– 50 100 1000 
+ 100 200 1500 
CAP indicates Cellulose acetate phthalate; EC indicates Ethyl cellulose 
Table 2: Composition of diclofenac sodium microcapsules as per 2
3
 factorial designs 
 
Combination 
 
Formulation 
 Compositiona 
X1 X2  X3 
1 F1 - - - 
A F2 + - - 
B F3 - + - 
AB F4 + + - 
C F5 - - + 
AC F6 + - + 
BC F7 - + + 
ABC F8 + + + 
a Factor at low level, -; Factor at high level, + 
 
RESULT AND DISCUSSION 
Diclofenac sodium is poorly soluble in gastric medium. As 
a result it possesses absorption problems in gastric 
medium. Hence an attempt was made to avoid the adverse 
reactions of diclofenac sodium. Diclofenac sodium is a 
NSAID and is presently considered as important drug for 
treatment of rheumatoid arthritis. Its successful treatment 
can be achieved by maintaining constant supply of drug. 
Multiple dose administration at intervals of 6 – 8 hours is 
difficult for a arthritic patient, which can lead to patient 
non compliance. Diclofenac sodium with all evident 
advantages has proved to be a suitable candidate for 
development of controlled release dosage form. In this 
study, the microcapsules were prepared by employing wet 
granulation and thermal change methods simultaneously. 
The method of preparation of these dual coated 
microcapsules is based on the simple idea that the mixture 
of CAP and drug is first converted into uniform granules 
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(to act as a core) employing wet granulation method and 
subsequently EC was coated using thermal change method 
which resulted in the formulation of dual coated 
microcapsules. The technique involved the principle of 
solvent evaporation. The compositions of formulations 
were varied as per factorial design and factor concentration 
of CAP and concentration of EC were considered to have 
an important effect on the release from the prepared 
microcapsules. The prepared microcapsules were subjected 
to various evaluations. Surface morphology, as shown in 
Fig 1 revealed that the prepared microcapsules were 
discrete and spherical in shape. Micromeritic analysis 
revealed that the mode of size distribution was normal in 
all batches with the range distribution of 414.14 ± 3.43 – 
787.19 ± 3.25µm. Results of measurements of the angle of 
repose of the microcapsules are summarized in Table 3. 
The values in the range of 19.46 ± 2.13 – 27.02 ± 2.66 for 
all batches revealed that they have a good flow property 
(10) which is desired parameter for further processing. The 
drug content of diclofenac sodium was found to be in the 
range of 301.85 – 448.1mg. Fourier Transform Infrared 
(FTIR) spectra for the pure drug were recorded and 
compared with the FTIR spectra of the formulations for 
determining drug excipient interaction and shown in figure 
4. Diclofenac sodium gives characteristic peaks at wave 
numbers 756, 775, 1286, 1308, 1504 and 1572 (11). FTIR 
studies revealed that there was no shift in peaks of the 
formulations containing diclofenac sodium and other 
excipients when compared to pure diclofenac sodium, 
indicating there was no interaction between diclofenac 
sodium and other polymers used.  Release profiles from 
the 8 formulations according to 23 factorial designs are 
shown in Figs. 2 & 3. In vitro dissolution studies were 
carried out in two dissolution medium – 0.1N HCl solution 
for first two hours and then in phosphate buffer pH 7.4 for 
next 8 hours. It is clear from the figures that the 
formulation showed biphasic release of diclofenac sodium. 
Release of diclofenac sodium solution was lesser in 0.1N 
HCl. The design was evaluated for a factorial linear first 
order model: 
Y = b0 + b1X1 + b2X2 + b3X3 + b12X1X2 + b13X1X3 + 
b23X2X3  
Coefficients with one factor indicate the effect of that 
particular factor, while the coefficients with more than one 
factor and those with second order terms represent the 
interaction between those factors and quadratic nature of 
the phenomena, respectively. Positive sign of the term 
indicates positive (additive) effect, while negative sign 
indicates negative (antagonistic) effect of the factor on the 
response (13). Two-dimensional contour plots are 
presented in Figs. 5–7, which are very useful to study the 
interaction effects of the factors on the responses. These 
types of plots are useful in study of the effects of two 
factors on the response at one time. All the relationships 
among the three variables are linear, although Figs. 5 and 6 
exhibit a nearly non linear relationship of factor X1 with 
factors X2, in the form of curvilinear or non linear lines at 
the lowest and highest level of polymer concentration. At 
medium polymer concentrations these become linear. 
 
 
Table 3: Responses for formulation (F1 – F8) by 23 factorial design  
 
Batch 
code 
Y1 
 
Yield 
(%) 
Y2 
Diclofenac 
Sodium 
release after 
8 hours, (%) 
Y3 
Diffusion 
coefficient 
(n) 
Y4 
Drug 
Entrapment 
Efficiency  
(DEE) (%) 
Angle of 
repose 
(θ) 
Average 
particle size 
(µm) 
Dissolution 
efficiency 
(DE) 
(%)  
Mean 
Dissolution 
Time 
(MDT) 
F1 69.12 78.54 0.79 60.37±0.56 19.46±2.13 475.35±4.12 59.05 6.037 
F2 75.50 69.97 1.27 82.18±1.43 24.06±3.22 682.21±3.17 54.79 6.169 
F3 70.74 73.62 1.09 86.74±2.33 20.25±2.76 414.14±3.43 57.96 5.985 
F4 82.90 60.12 1.42 89.62±4.21 24.99±4.10 702.16±2.14 53.31 6.208 
F5 68.90 74.35 0.98 64.28±2.11 24.27±3.35 598.51±3.65 59.24 6.008 
F6 76.08 70.13 1.20 62.41±3.76 23.02±3.26 640.74±4.09 51.56 5.521 
F7 71.04 78.32 1.21 66.88±2.13 25.04±4.21 632.34±2.89 46.50 5.782 
F8  83.88 59.17 1.25 83.19±1.25 27.02±2.66 787.19±3.25 46.25 6.386 
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Table 4: Regression coefficients for the responses 
Y1 = 74.77 + 4.82X1 + 2.37X2  
Y2 = 70.53 – 5.68X1 – 2.72X2 – 2.48X1X2 
Y3 = 1.15 + 0.133X1 + 0.09X2  
Y4 = 74.46 + 4.89X1 + 7.15X2 – 5.27X3 
 
Table 5: Analysis of Variance table for dependent variables from Full Factorial Design* 
Source  df Sum Square Mean Square F Value Prob > F 
Yield of the prepared microcapsules (%) R2 = 0.9311 
X1 1 185.86 185.86 54.42 0.0007 
X2 1 44.94 44.94 13.16 0.0151 
      
Diclofenac Sodium release at 8 hours (%) R2 = 0.9476 
X1 1 258.10 258.10 50.89 0.0020 
X2 1 59.19 59.19 11.67 0.0269 
X1X2 1 49.30 49.30 9.72 0.0356 
      
Diffusion Coefficient (n) R2 = 0.7892 
X1 1 0.14 0.14 12.71 0.0161 
X2 1 0.068 0.068 6.01 0.0578 
      
Drug Entrapment Efficiency (DEE) R2 = 0.8052 
X1 1 191.39 191.39 3.85 0.1213 
X2 1 408.84 408.84 8.22 0.0456 
X3 1 222.08 222.08 4.47 0.1021 
* Prob > F less than 0.05 indicate model terms are significant  
In the case of Y2 (percentage of diclofenac release after 8 
hours), coefficients b1 and b2 were found to be significant, 
with an interaction of b12. In Table 4, we can see only 
negative coefficients. When the total polymer content to 
drug ratio was increased, diclofenac sodium release after 8 
hours decreased.  
 
Figure 1. Scanning electron microscopy (SEM) of microcapsules 
Conclusion 
This article discussed a positive application of a computer 
optimization technique for the development of dual coated 
microcapsules in which the amount of polymer cellulose 
acetate phthalate (CAP) and ethyl cellulose (EC) did 
significantly affect the studied dependent variables. 
However, the stirring speed during preparation did not 
significantly affect the dependent variables. The dosage 
form can control the release, avoid dose dumping and 
extend the duration of action of a drug. This dosage form 
holds promise for in vivo studies, which can be 
extrapolated for the development of other delivery 
systems.  
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Figure 4: Counter plot 
showing the effect of 
amount of CAP (X1) and 
amount of EC (X2) on the 
yield of the microcapsules 
(Y1) 
Figure 7: Counter plot 
showing the effect of amount 
of CAP (X1) and amount of 
EC (X2) on the Drug 
Entrapment Efficiency (Y4) 
 
Figure 6: Coulter plot 
showing the effect of 
amount of CAP (X1) and 
amount of EC (X2) on the 
diffusion coefficient (n) 
(Y3) 
 
Figure 5: Counter plot 
showing the effect of amount 
of CAP (X1) and amount of 
EC (X2) on the percentage of 
diclofenac sodium at 8 hours 
(Y2) 
 
   
Figure 2. In vitro release profile (formulations F1 to F4) Figure 3. In vitro release profile (formulations F5 to F8) 
 
Figure 4. FTIR spectrum of pure diclofenac and formulation  
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